Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles

Published:2020-01-01 Issue:1 Volume:27 Page:358-366
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Li Zhanrong¹,Guo Zhihua¹,Chu Dandan¹,Feng Huayang¹,Zhang Junjie¹,Zhu Lei¹,Li Jingguo¹^ORCID

Affiliation:

1. Henan Eye Hospital, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Zhengzhou, P. R. China

Funder

the National Natural Science Foundation of China

National Key R&D Program of China

Medical Science and Technology Program of Henan Province

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2020.1730522

Reference30 articles.

1. Superselective Ophthalmic Artery Chemotherapy as Primary Treatment for Retinoblastoma (Chemosurgery)

2. Treatment of Retinoblastoma in 2015

3. γ-Tocotrienol modulates the paracrine secretion of VEGF induced by cobalt(II) chloride via ERK signaling pathway in gastric adenocarcinoma SGC-7901 cell line

4. Retinoblastoma

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges;Drug Delivery and Translational Research;2024-07-13

2. Prodrug-inspired adenosine triphosphate–activatable celastrol-Fe(III) chelate for cancer therapy;Science Advances;2024-07-12

3. Design and investigation of celastrol‐peptide nanoassemblies and their binding interactions with superoxide dismutase 1 and its mutants;Nano Select;2024-06-11

4. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics;International Journal of Pharmaceutics;2024-06

5. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma;Molecules;2024-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3